The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth
- 9 October 2001
- Vol. 277 (1-2) , 15-30
- https://doi.org/10.1016/s0378-1119(01)00696-5
Abstract
No abstract availableKeywords
This publication has 138 references indexed in Scilit:
- P53 mutants without a functional tetramerisation domain are not oncogenic 1 1Edited by A. R. FershtJournal of Molecular Biology, 1999
- Cancer phenotype correlates with constitutional TP53 genotype in families with the Li–Fraumeni syndromeOncogene, 1998
- Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formationThe EMBO Journal, 1998
- Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesisOncogene, 1998
- The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostabilityJournal of Molecular Biology, 1998
- Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potentialOncogene, 1997
- How Phosphorylation Regulates the Activity of p53Journal of Molecular Biology, 1996
- A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53–deficient miceNature Genetics, 1995
- Tumor spectrum analysis in p53-mutant miceCurrent Biology, 1994
- Wild‐type murine p53 represses transcription from the murine c‐myc promoter in a human glial cell lineJournal of Cellular Biochemistry, 1992